BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34502357)

  • 1. Novel Sulfonamide-Based Carbamates as Selective Inhibitors of BChE.
    Magar P; Parravicini O; Štěpánková Š; Svrčková K; Garro AD; Jendrzejewska I; Pauk K; Hošek J; Jampílek J; Enriz RD; Imramovský A
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proline-Based Carbamates as Cholinesterase Inhibitors.
    Pizova H; Havelkova M; Stepankova S; Bak A; Kauerova T; Kozik V; Oravec M; Imramovsky A; Kollar P; Bobal P; Jampilek J
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29135926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAR-mediated Similarity Assessment of the Property Profile for New, Silicon-Based AChE/BChE Inhibitors.
    Bak A; Pizova H; Kozik V; Vorcakova K; Kos J; Treml J; Odehnalova K; Oravec M; Imramovsky A; Bobal P; Smolinski A; Trávníček Z; Jampilek J
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
    Pejchal V; Štěpánková Š; Pejchalová M; Královec K; Havelek R; Růžičková Z; Ajani H; Lo R; Lepšík M
    Bioorg Med Chem; 2016 Apr; 24(7):1560-72. PubMed ID: 26947959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Benzene-Based Carbamates for AChE/BChE Inhibition: Synthesis and Ligand/Structure-Oriented SAR Study.
    Bak A; Kozik V; Kozakiewicz D; Gajcy K; Strub DJ; Swietlicka A; Stepankova S; Imramovsky A; Polanski J; Smolinski A; Jampilek J
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors.
    Horáková E; Drabina P; Brož B; Štěpánková Š; Vorčáková K; Královec K; Havelek R; Sedlák M
    J Enzyme Inhib Med Chem; 2016; 31(sup3):173-179. PubMed ID: 27476673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Hybrid SAR Property Modeling of Novel Cholinesterase Inhibitors.
    Kos J; Kozik V; Pindjakova D; Jankech T; Smolinski A; Stepankova S; Hosek J; Oravec M; Jampilek J; Bak A
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
    Wu J; Pistolozzi M; Liu S; Tan W
    Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Cholinesterase Inhibitors Based on O-Aromatic N,N-Disubstituted Carbamates and Thiocarbamates.
    Krátký M; Štěpánková Š; Vorčáková K; Švarcová M; Vinšová J
    Molecules; 2016 Feb; 21(2):. PubMed ID: 26875979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of salicylanilide and 4-chlorophenol-based N-monosubstituted carbamates as potential inhibitors of acetyl- and butyrylcholinesterase.
    Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
    Bioorg Chem; 2018 Oct; 80():668-673. PubMed ID: 30059892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, molecular docking and molecular dynamics studies of novel tacrine-carbamate derivatives as potent cholinesterase inhibitors.
    Ozten O; Zengin Kurt B; Sonmez F; Dogan B; Durdagi S
    Bioorg Chem; 2021 Oct; 115():105225. PubMed ID: 34364052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Compounds for Butyrylcholinesterase Inhibition.
    Li S; Li AJ; Travers J; Xu T; Sakamuru S; Klumpp-Thomas C; Huang R; Xia M
    SLAS Discov; 2021 Dec; 26(10):1355-1364. PubMed ID: 34269114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro evaluation of new derivatives of 2-substituted-6-fluorobenzo[d]thiazoles as cholinesterase inhibitors.
    Imramovský A; Pejchal V; Štěpánková Š; Vorčáková K; Jampílek J; Vančo J; Šimůnek P; Královec K; Brůčková L; Mandíková J; Trejtnar F
    Bioorg Med Chem; 2013 Apr; 21(7):1735-48. PubMed ID: 23462716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing of promising medicinal scaffolds for Alzheimer's disease through enzyme inhibition, lead optimization, molecular docking and dynamic simulation approaches.
    Hassan M; Abbasi MA; Aziz-Ur-Rehman ; Siddiqui SZ; Shahzadi S; Raza H; Hussain G; Shah SAA; Ashraf M; Shahid M; Seo SY; Malik A
    Bioorg Chem; 2019 Oct; 91():103138. PubMed ID: 31446329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
    Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
    Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors.
    Bajda M; Łątka K; Hebda M; Jończyk J; Malawska B
    Bioorg Chem; 2018 Aug; 78():29-38. PubMed ID: 29529519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
    Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
    J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.